News Headlines Article

Deals puts Big Pharma, UCSF researchers side by side targeting cancer, obesity and more
San Francisco Business Times

Researchers from drug giant GlaxoSmithKline and the University of California, San Francisco, will work together to accelerate promising basic science in cancer, obesity and infectious diseases toward new drugs. Specific financial terms of the deal weren’t disclosed, but GlaxoSmithKline (NYSE: GSK) will give early-stage funding for academic discoveries that struggle to receive money via traditional grants.